Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,821 | -12,922 | -5,020 | -37,645 | -33,225 |
| Depreciation Amortization | 722 | 545 | 265 | 454 | 198 |
| Accounts payable and accrued liabilities | -376 | -76 | -61 | -701 | -226 |
| Other Working Capital | -1,759 | -2,843 | -1,286 | -469 | -359 |
| Other Operating Activity | 1,169 | 3,495 | 1,394 | 24,409 | 23,503 |
| Operating Cash Flow | $-17,064 | $-11,802 | $-4,708 | $-13,952 | $-10,108 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -336 | 1,110 | 1,142 | 5,520 | 5,527 |
| Other Investing Activity | 0 | 0 | 0 | 1,077 | 1,077 |
| Investing Cash Flow | $-336 | $1,110 | $1,142 | $6,597 | $6,604 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 4,974 | 4,974 |
| Debt Repayment | N/A | N/A | N/A | -259 | N/A |
| Common Stock Issued | 83,557 | 83,557 | 85,653 | N/A | 11,735 |
| Other Financing Activity | 0 | 0 | 0 | 11,729 | -243 |
| Financing Cash Flow | $83,557 | $83,557 | $85,653 | $16,443 | $16,466 |
| Beginning Cash Position | 10,337 | 10,337 | 10,337 | 1,249 | 1,249 |
| End Cash Position | 76,493 | 83,201 | 92,423 | 10,337 | 14,211 |
| Net Cash Flow | $66,156 | $72,864 | $82,087 | $9,088 | $12,962 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,064 | -11,802 | -4,708 | -13,952 | -10,108 |
| Capital Expenditure | -1,554 | -36 | -3 | -13 | -6 |
| Free Cash Flow | -18,618 | -11,837 | -4,711 | -13,965 | -10,113 |